Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Average Recommendation of “Buy” from Brokerages
Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) have been given an average recommendation of “Buy” by the nine research firms that are covering the company, MarketBeat Ratings reports. Nine investment analysts have rated the stock with a buy rating. The average 1 year target price among brokerages that have issued ratings […]
More Stories
McCormick & Company, Incorporated (NYSE:MKC) Declares $0.42 Quarterly Dividend
McCormick & Company, Incorporated (NYSE:MKC – Get Free Report) declared a quarterly dividend on Tuesday, June 25th, RTT News reports....
CD Private Equity Fund III (CD3) To Go Ex-Dividend on July 9th
CD Private Equity Fund III (ASX:CD3 – Get Free Report) announced a interim dividend on Friday, July 5th, MarketIndexAU reports....
The Walt Disney Company (NYSE:DIS) Announces Semi-annual Dividend of $0.45
The Walt Disney Company (NYSE:DIS – Get Free Report) declared a semi-annual dividend on Wednesday, February 7th, Wall Street Journal...
United Security Bancshares Plans Quarterly Dividend of $0.12 (NASDAQ:UBFO)
United Security Bancshares (NASDAQ:UBFO – Get Free Report) announced a quarterly dividend on Tuesday, June 25th, Zacks reports. Shareholders of...
Sylvamo Co. (NYSE:SLVM) Plans Quarterly Dividend of $0.45
Sylvamo Co. (NYSE:SLVM – Get Free Report) announced a quarterly dividend on Friday, May 17th, Zacks reports. Investors of record...
Intact Financial Co. (TSE:IFC) Receives Average Recommendation of “Moderate Buy” from Brokerages
Shares of Intact Financial Co. (TSE:IFC – Get Free Report) have received an average rating of “Moderate Buy” from the...